470 related articles for article (PubMed ID: 29198062)
1. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
2. A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation.
Stegmayr BG; Jonsson P; Mahmood D
Int J Artif Organs; 2013 Jan; 36(1):1-6. PubMed ID: 23280073
[TBL] [Abstract][Full Text] [Related]
3. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
Trials; 2013 Jun; 14():163. PubMed ID: 23725299
[TBL] [Abstract][Full Text] [Related]
5. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
[TBL] [Abstract][Full Text] [Related]
6. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
Wright S; Steinwandel U; Ferrari P
Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
[TBL] [Abstract][Full Text] [Related]
8. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
9. Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.
Vanommeslaeghe F; De Somer F; Josipovic I; Boone M; Dhondt A; Van Biesen W; Eloot S
Artif Organs; 2019 Aug; 43(8):756-763. PubMed ID: 30820962
[TBL] [Abstract][Full Text] [Related]
10. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
[TBL] [Abstract][Full Text] [Related]
11. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
Româo JE; Fadil MA; Sabbaga E; Marcondes M
Nephrol Dial Transplant; 1997 Jan; 12(1):106-10. PubMed ID: 9027783
[TBL] [Abstract][Full Text] [Related]
12. Heparin albumin priming in a clinical setting for hemodialysis patients at risk for bleeding.
Skagerlind M; Stegmayr B
Hemodial Int; 2017 Apr; 21(2):180-189. PubMed ID: 27576541
[TBL] [Abstract][Full Text] [Related]
13. Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.
Kalicki RM; Aregger F; Alberio L; Lämmle B; Frey FJ; Uehlinger DE
Thromb Haemost; 2007 Dec; 98(6):1200-7. PubMed ID: 18064314
[TBL] [Abstract][Full Text] [Related]
14. Haemodialysis in patients treated with oral anticoagulant: should we heparinize?
Krummel T; Scheidt E; Borni-Duval C; Bazin D; Lefebvre F; Nguyen P; Hannedouche T
Nephrol Dial Transplant; 2014 Apr; 29(4):906-13. PubMed ID: 24459138
[TBL] [Abstract][Full Text] [Related]
15. Simple citrate anticoagulation protocol for low flux haemodialysis.
Lim EK; Seow YT; Chen SE; Yang G; Liaw ME; Isaac S
BMC Nephrol; 2018 Jan; 19(1):16. PubMed ID: 29351783
[TBL] [Abstract][Full Text] [Related]
16. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
[TBL] [Abstract][Full Text] [Related]
17. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
19. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
Naumnik B; Borawski J; Myśliwiec M
Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
[TBL] [Abstract][Full Text] [Related]
20. Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure.
Boccardo P; Melacini D; Rota S; Mecca G; Boletta A; Casiraghi F; Gianese F
Nephrol Dial Transplant; 1997 Nov; 12(11):2349-54. PubMed ID: 9394322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
